U.S. Transportation Stock News

NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

MannKind (MNKD) Wins Breakthrough T1D Grant, Is The Stock Still 11% Undervalued?

What the Breakthrough T1D grant means for MannKind The new Breakthrough T1D grant for MannKind (MNKD) and its INHALE-1 study puts Afrezza’s pediatric program in focus, coming shortly after FDA approval for children aged 6 and older. For you as an investor, the grant does two things at once. It validates Afrezza as a research priority within the type 1 diabetes community, and it helps support clinical work that MannKind would otherwise need to fund on its own. The INHALE-1 trial is centered on...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

How Broad Russell Index Additions At Rapport Therapeutics (RAPP) Have Changed Its Investment Story

In late June 2026, Rapport Therapeutics, Inc. was added to several Russell growth and small-cap benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices. This broad inclusion across multiple Russell growth and microcap indices can significantly raise the company’s profile among institutional and index-tracking investors. Next, we’ll explore how this broad Russell index inclusion could influence Rapport Therapeutics’ investment narrative, particularly around...
NYSE:KNF
NYSE:KNFBasic Materials

Knife River (KNF) Removed From Russell Indexes As Undervalued Narrative Faces A Fresh Test

Knife River (KNF) has been removed from both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, a change that can influence index fund flows and short term trading interest. See our latest analysis for Knife River. Knife River’s removal from the Russell 2000 Defensive indexes comes after a mixed stretch in trading, with the stock down 8.63% on a 7 day share price return but still showing a 16.69% year to date share price return and a 3 year total shareholder return...
NYSE:AGM
NYSE:AGMDiversified Financial

How Investors Are Reacting To Federal Agricultural Mortgage (AGM) Resilient Rural Lending Strengthening Its Investment Narrative

In recent coverage of Federal Agricultural Mortgage, analysts highlighted how its diversified segments across Farm & Ranch, Corporate AgFinance, and Infrastructure Finance helped it handle industry headwinds from elevated mortgage rates while delivering double-digit year-over-year gains in business volume, revenues, and core earnings earlier in 2026. An interesting angle is how this multi-segment footprint in rural America, combined with disciplined underwriting and steady customer demand,...
NYSE:MBGL
NYSE:MBGLProfessional Services

Is Mobility Global (MBGL) Cheap Following Its Spin Off From S&P Global?

Mobility Global (MBGL) has just completed its spin off from S&P Global, with shares distributed to existing S&P Global investors and trading beginning on the New York Stock Exchange on July 1, 2026. See our latest analysis for Mobility Global. After the spin off, Mobility Global’s 1 day share price return declined 6.56% and its year to date share price return is down 5.69%. This suggests early trading pressure even as the stock joins multiple global indices and completes a broad board...
NYSE:IBP
NYSE:IBPConsumer Durables

How New 21st Century ROAD to Housing Act At Installed Building Products (IBP) Has Changed Its Investment Story

Earlier this week, Congress passed the bipartisan 21st Century ROAD to Housing Act, a housing-focused law that investors expect to support construction-related businesses such as Installed Building Products. The legislation’s emphasis on addressing housing demand has drawn attention to companies leveraged to commercial and multifamily construction, spotlighting Installed Building Products’ positioning across these segments. Next, we’ll examine how the new housing law’s focus on demand and...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Harrow (HROW) Could Be 38% Undervalued Following BYOOVIZ Launch

Why Harrow stock is in focus after the BYOOVIZ launch Harrow (HROW) is back on investors’ radar after launching BYOOVIZ in the US, a Lucentis biosimilar that carries FDA interchangeability status for several retinal conditions tied to anti VEGF treatment. See our latest analysis for Harrow. Harrow’s official BYOOVIZ launch comes after a sharp 28.27% 1 month share price gain and a 21.04% 3 month share price return, while the year to date share price is still down 14.37%. Over the longer term,...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Did FDA’s Facility-Related LNTH-2501 Delay and Russell Additions Just Reframe Lantheus Holdings’ (LNTH) Risk Profile?

In late June 2026, Lantheus Holdings reported that the FDA issued a Complete Response Letter for its LNTH-2501 PET imaging kit for somatostatin receptor‑positive neuroendocrine tumors, citing unresolved third‑party manufacturing facility issues rather than concerns about the product’s safety, efficacy, or supporting data. Separately, the company was added to both the Russell 2000 Defensive Index and the Russell 2000 Growth‑Defensive Index, highlighting its growing profile within defensive...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

How Marex’s Shift to Bermuda and Russell 2000 Exit At Marex Group (MRX) Has Changed Its Investment Story

Marex Group plc recently completed its redomiciliation from England and Wales to Bermuda, following shareholder approval, global regulatory clearances, and sanction by the English High Court, with the move becoming effective on 1 July 2026. This shift places Marex under Bermuda’s US-style corporate law, aligning more closely with its Nasdaq listing and aiming to simplify its structure and reduce operating costs. We’ll now examine how Marex’s move to Bermuda, alongside its removal from...
NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

Does StoneCo’s Russell Index Additions and Upbeat Forecasts Change The Bull Case For STNE?

In late June 2026, StoneCo Ltd. (NasdaqGS: STNE) was added to multiple Russell value indexes, including the Russell 2000, 2500, 3000, 3000E and Small Cap Comp Value benchmarks. This wave of index inclusions coincides with upbeat analyst expectations ahead of StoneCo’s upcoming earnings release, including a favorable Zacks Rank of #2 (Buy) and projected earnings and revenue growth. We’ll now examine how this combination of index additions and upbeat analyst sentiment may influence StoneCo’s...
NYSE:CNA
NYSE:CNAInsurance

CNA Financial (CNA) Could Be 44% Undervalued On A Strong Share Price Run

CNA Financial (CNA) has drawn attention after its stock rose 3.1% on July 2 to $51.17, trading modestly above one valuation estimate while carrying an Above Average GF Score of 63/100. See our latest analysis for CNA Financial. The recent 3.1% move adds to a strong run for CNA Financial, with a 30-day share price return of 21.14% and a 1-year total shareholder return of 21.52%, indicating momentum that contrasts with moderate concerns flagged in its GF Score. If this kind of sustained...
NYSE:WEX
NYSE:WEXDiversified Financial

Premium Credit Card Trends Put Jack Henry, Klarna And WEX Stock In Focus

Premium credit cards are turning into lifestyle passes, with American Express, Chase and rivals racing to win affluent cardholders through airport lounges, event access and higher tier perks. With annual fees at the top end now reaching hundreds of dollars, the gap between premium and mass market customers is widening, and fee income is becoming more concentrated among high spenders. This article looks at three stocks from our Premium Consumer Finance Stocks screener that appear especially...
NasdaqGS:FA
NasdaqGS:FAProfessional Services

First Advantage (FA) Is Up 15.2% After Earnings Beat And S&P SmallCap 600 Inclusion – What’s Changed

In recent weeks, First Advantage reported first-quarter 2026 results that exceeded analyst expectations and confirmed its upcoming inclusion in the S&P SmallCap 600 index, reinforcing its profile within the employment screening and digital identity market. This combination of an earnings beat and index addition underscores how operational outperformance and higher index visibility can reshape how investors view First Advantage’s role in outsourced verification services. Now, we’ll explore...
NYSE:ASA
NYSE:ASACapital Markets

ASA Gold And Precious Metals (ASA) Reshuffles Leadership, Is The Stock Already Pricey?

ASA Gold and Precious Metals (ASA) is in the spotlight after Axel Merk urged the Securities and Exchange Commission to review recent board decisions that shifted portfolio management from Merk Investments to an internal, Saba affiliated investment committee. See our latest analysis for ASA Gold and Precious Metals. That governance fight is unfolding against a mixed backdrop for ASA Gold and Precious Metals, with the share price at $54.48 after a 1 day share price return of 4.03%, a 30 day...
NasdaqGS:HBNC
NasdaqGS:HBNCBanks

Horizon Bancorp (HBNC) Faces Jury Verdict, Is The Stock Still Trading At A Discount?

Horizon Bancorp (HBNC) is back in focus after a June 24, 2026 jury verdict ordered nearly US$3.0 million in damages tied to a 2018 auto repossession and credit reporting dispute. See our latest analysis for Horizon Bancorp. The verdict hit Horizon Bancorp’s stock in the short term, with a 1 day share price return of down 3.42% and a 7 day share price return of down 2.51%. That sits against a 30 day share price return of 8.86% and a year to date share price return of 19.59%, alongside a 3 year...
NYSE:RAMP
NYSE:RAMPSoftware

LiveRamp Holdings (RAMP) Looks 40% Undervalued As Adobe Integration Fuels Growth Hopes

LiveRamp Holdings (RAMP) is drawing fresh attention after announcing a new integration with Adobe GenStudio for Commerce Media Networks, linking its commerce purchase data directly into Adobe’s agentic content supply chain. See our latest analysis for LiveRamp Holdings. LiveRamp Holdings’ integration news lands at a time when the stock’s recent momentum has been strong, with a 90 day share price return of 38.92% and a year to date share price return of 37.60%. At the same time, the 3 year...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Is Innoviva (INVA) Trading Index Membership for a Deeper Bet on Nortiva Bio’s LYNX Platform?

In late June 2026, Innoviva, Inc. was removed from multiple Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth benchmarks. This wave of index deletions coincided with Innoviva’s efforts to build out Nortiva Bio around the LYNX long-acting oral drug delivery platform, highlighting a shifting profile for the company. We’ll now examine how Innoviva’s removal from several Russell growth indices could influence its investment narrative for existing and prospective...
NYSE:UNF
NYSE:UNFCommercial Services

What UniFirst (UNF)'s Rising Sales, Weaker Earnings and Buybacks Mean For Shareholders

In the past quarter ended May 30, 2026, UniFirst Corporation reported sales of US$634.4 million, up from US$610.78 million a year earlier, while net income fell to US$19.92 million and diluted EPS from continuing operations declined to US$1.09. Over the first nine months of fiscal 2026, UniFirst grew sales to US$1.88 billion but saw net income and EPS weaken, even as it completed a US$91.49 million buyback program covering 529,910 shares. We’ll now examine how UniFirst’s revenue growth...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

How Investors May Respond To Option Care Health (OPCH) Joining Multiple Russell Value and Small‑Cap Indices

On 27 June 2026, Option Care Health, Inc. was added to multiple Russell value and small-cap indices, including the Russell 2000 Value, Russell 2500 Value, Russell 3000 Value, Russell 3000E Value, and Russell Small Cap Comp Value benchmarks, while being removed from the Russell 2000 Dynamic Index. This broad index inclusion increases the company’s visibility among institutional investors and index-tracking funds, potentially influencing trading volumes and liquidity given the breadth of these...
NYSE:AMR
NYSE:AMRMetals and Mining

Alpha Metallurgical Resources (AMR) Could Be 18% Undervalued On Russell Index Removal

Index removal reshapes the backdrop for Alpha Metallurgical Resources Alpha Metallurgical Resources (AMR) has been removed from the Russell 2000 Growth Defensive, Value Defensive, and Defensive Indexes, an index reshuffle that could prompt ownership changes as rules-based funds realign their portfolios. This type of index removal often affects how indexed and quantitative investors treat a stock, even when a company’s underlying coal operations, revenue mix, and financial profile remain...
NYSE:ADM
NYSE:ADMFood

Sleep Well At Night With 3 Defensive Dividend Stocks

With weaker US jobs data, rising borrowing costs, and rate hike worries tugging at sentiment, many investors are rethinking how much risk they want to take. Defensive dividend stocks, with larger market caps, sturdy balance sheets, and a record of paying consistent income, can look relatively steady when growth stories feel less certain. This article explains how the latest macro signals around jobs, yields, and manufacturing might influence that corner of the market, and highlights 3 stocks...
NYSE:LAD
NYSE:LADSpecialty Retail

Does Removal From Russell Growth Indexes Change The Bull Case For Lithia Motors (LAD)?

In late June 2026, Lithia Motors, Inc. (NYSE:LAD) was removed from several major Russell growth benchmarks, including the Russell 1000, 2500, 3000, 3000E, Small Cap Composite, and Midcap Growth indexes. This broad exclusion from key passive benchmarks can alter how index-tracking and growth-focused funds view Lithia, potentially reshaping its shareholder base and liquidity profile. Next, we will examine how Lithia’s removal from multiple Russell growth indexes may influence its existing...